title: Ineffectiveness of AL721 in HIV disease.
authors.forename: B S
authors.initials: BS
authors.lastname: Peters
authors.forename: J M
authors.initials: JM
authors.lastname: Bennett
authors.forename: D J
authors.initials: DJ
authors.lastname: Jeffries
authors.forename: K
authors.initials: K
authors.lastname: Knox
authors.forename: A
authors.initials: A
authors.lastname: Kocsis
authors.forename: A J
authors.initials: AJ
authors.lastname: Pinching
mesh_terms: D000386:AIDS-Related Complex / Q000188:drug therapy; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D005989:Glycerides / Q000627:therapeutic use*; D015488:HIV Antigens / Q000032:analysis; D006801:Humans; D008297:Male; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D010714:Phosphatidylethanolamines / Q000627:therapeutic use*; D010865:Pilot Projects
chemical_list: D004338:Drug Combinations; D005989:Glycerides; D015488:HIV Antigens; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; C046637:neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination